Lean Fatty Liver: Can You Have It at a Normal Weight?

TL;DR

• Lean fatty liver is real and fairly common. In a 2020 meta-analysis, about 1 in 5 people with fatty liver (19.2%) had a normal BMI, and roughly 5% of the general population had lean fatty liver.
• Having a normal weight doesn’t protect against scarring. In the same analysis, 29.2% of lean or non-obese people with fatty liver had significant fibrosis (stage 2 or higher), though the studies varied a lot.
• Treatment focuses on diet quality, activity (including resistance training) and the metabolic drivers, not on losing large amounts of weight. Ask your doctor to check your scarring risk.

Yes, you can have fatty liver at a normal weight. Studies find that around one in five people with fatty liver is lean, and being lean doesn’t mean the liver is free of inflammation or scarring. BMI is a rough measure that says little about where your body stores fat or how well it handles sugar.

This guide explains how lean MASLD (metabolic dysfunction-associated steatotic liver disease, formerly NAFLD) is defined, how common it is, what may cause it, how risky it is, and what the guidelines say about managing it. Much of the research is observational and the field is evolving, so where numbers vary I’ll say so.

What Is Lean Fatty Liver?

“Lean” means a normal body weight by BMI, but the cutoff differs by source. The AASLD describes fatty liver in non-overweight people as a BMI under 25 kg/m², or under 23 kg/m² in Asian individuals. The 2024 European guideline defines normal-weight MASLD as MASLD in someone with a BMI under 25 kg/m², using ethnicity-specific cutoffs.

Many studies report “non-obese” and “lean” separately. They overlap but differ, and it matters when comparing numbers: “non-obese” includes people with overweight, who are not lean.

How Do You Get Diagnosed with MASLD at a Normal Weight?

The MASLD definition from the 2023 international consensus requires fat in the liver (steatosis) plus at least one of five cardiometabolic criteria. Weight is only one of them. A lean person can qualify through any of the others:

Criterion	Cutoff
Body size	BMI at or above 25 kg/m² (23 in Asian populations), or a large waist: over 94 cm in men or 80 cm in women (ethnicity-adjusted cutoffs exist)
Blood sugar	Fasting glucose 100 mg/dL (5.6 mmol/L) or higher, 2-hour glucose 140 mg/dL (7.8 mmol/L) or higher, HbA1c 5.7% or higher, or type 2 diabetes or its treatment
Blood pressure	130/85 mmHg or higher, or treatment
Triglycerides	150 mg/dL (1.70 mmol/L) or higher, or lipid-lowering treatment
HDL cholesterol	40 mg/dL (1.0 mmol/L) or lower in men, 50 mg/dL (1.3 mmol/L) or lower in women, or treatment

So a person with a normal BMI but a larger waist, borderline blood sugar or high triglycerides can have MASLD. People with fatty liver and none of these criteria fall under a different label (reviewers call it cryptogenic steatotic liver disease), and need a closer search for other causes. Our guide to MASLD vs NAFLD explains the new terminology.

How Common Is Lean Fatty Liver?

Prevalence figures depend on the definition and the country. The best-known pooled estimate is a 2020 systematic review and meta-analysis in The Lancet Gastroenterology & Hepatology (Ye et al.), covering 93 studies and more than 10 million people from 24 countries or areas:

Measure	Estimate (95% CI)
Share of people with NAFLD who were lean	19.2% (15.9–23.0)
Share of people with NAFLD who were non-obese	40.8% (36.6–45.1)
Lean NAFLD in the general population	5.1% (3.7–7.0)
Non-obese NAFLD in the general population	12.1% (9.3–15.6)

The authors noted that most analyses showed high heterogeneity, so these are central estimates with wide uncertainty. The AASLD gives a similarly wide range: from 4.1% in the United States to as high as 19% in Asia. A 2025 review states that lean NAFLD affects 5–20% of the worldwide NAFLD population, and that it is more common in Asian cohorts.

The takeaway isn’t the exact percentage. It’s that lean fatty liver is common enough that doctors shouldn’t screen only people with a high BMI, a conclusion the Ye et al. authors drew themselves.

What Causes Fatty Liver in Lean People?

Researchers don’t have a single answer, and the causes probably vary from person to person. These are the factors most often linked to lean fatty liver in reviews:

• Visceral fat. Fat stored deep in the abdomen around the organs can be high even when BMI is normal. It’s more metabolically active than fat under the skin and is linked to insulin resistance.
• Low muscle mass (sarcopenia). Muscle is a major place the body disposes of blood sugar. Less muscle can mean poorer glucose handling.
• Insulin resistance. The European guideline notes that normal-weight people with MASLD have a higher prevalence of metabolic alterations, including insulin resistance.
• Genetics. Variants in genes such as PNPLA3, TM6SF2 and MBOAT7 are described as significant determinants. Some studies suggest the PNPLA3 risk variant is more common in lean fatty liver, though this is still being worked out.
• Diet. Diets high in fructose and sugar-sweetened drinks, and low in fiber and protein, are discussed as contributors. A person can eat poorly and still have a normal BMI.
• Gut microbiome and bile acid metabolism. These are under study, and the evidence is early.

Other causes of fat in the liver also need to be ruled out, since they matter more when weight isn’t an obvious explanation. NIDDK lists alcohol, rapid weight loss or malnutrition, certain medicines (such as corticosteroids and estrogens), toxin exposure and rare genetic diseases such as Wilson disease. If you drink alcohol regularly, be upfront about it, because that changes the diagnosis and the advice. See alcohol and fatty liver.

Is Lean Fatty Liver Less Serious?

The honest answer is: not reliably, and the data point in different directions.

Reasons it might seem milder. The AASLD notes that initial biopsy findings in lean patients are typically milder than in people with overweight or obesity. The European guideline also reports that normal-weight people with MASLD have a lower incidence of cirrhosis.

Reasons not to relax.

• In the Ye et al. meta-analysis, among people with lean or non-obese NAFLD, 39.0% had NASH (the inflamed form), 29.2% had significant fibrosis (stage 2 or higher) and 3.2% had cirrhosis. These apply to the combined lean and non-obese group, and the confidence intervals were wide.
• The same review followed outcomes and found substantial long-term liver and non-liver comorbidities, including new-onset diabetes, cardiovascular disease and high blood pressure.
• The European guideline states that normal-weight people with fatty liver face a higher mortality risk despite the lower incidence of cirrhosis, and that the risk of severe fibrosis is elevated even in normal-weight postmenopausal women with MASLD.
• A 2025 review reported similar or elevated risks for all-cause mortality (about a 1.6-fold increase), advanced fibrosis, cirrhosis, liver cancer and cardiovascular disease compared with people with obesity, though evidence varies between studies.

Taken together, lean fatty liver should be treated as a real condition that needs checking for scarring. A normal weight isn’t a reason to skip the check. It also means doctors shouldn’t assume a lean person’s raised liver enzymes are harmless. To find out where you stand, look at liver fibrosis stages and the FIB-4 calculator.

Should Lean People with Fatty Liver Lose Weight?

Usually less than other people, if at all. The guidance is cautious:

• The AASLD states that recommending weight loss may not be appropriate for lean patients with NAFLD, but that dietary modifications and exercise may be beneficial.
• The European guideline cites a 12-month randomized trial in which a 3–5% weight reduction led to remission of MASLD, with remission in 50% of non-obese participants. The same guideline notes that there is currently no evidence about the effect of diet and/or exercise on liver histology in this group.
• A 2025 review suggests a modest weight reduction of about 3–5% for lean patients, compared with 7–10% in people with obesity, and puts the emphasis on diet quality rather than aggressive calorie restriction.

If you are at a healthy weight, don’t diet down on your own initiative. Losing muscle or crash dieting could work against you, and NIDDK notes that rapid weight loss and malnutrition can make liver disease worse. Ask your doctor whether any weight change is right for you, and for how much.

What Helps Lean Fatty Liver?

With less weight to lose, the plan leans on food quality, movement and the metabolic drivers. These steps match the general guideline advice and the lean-specific review, but trials in lean people are limited.

1. Cut sugary drinks first. Fructose and sugar-sweetened beverages are the clearest dietary target. The AASLD notes that excess fructose raises the risk of MASLD, MASH and advanced fibrosis. Our guides to soda and sugar explain more.
2. Eat a Mediterranean-style pattern. Vegetables, legumes, whole grains, fish, nuts and olive oil, with fewer ultra-processed foods. The fatty liver diet guide covers what a day looks like.
3. Get enough protein and fiber. Reviews link low intake to lean fatty liver. Discuss protein with your doctor if you have kidney disease.
4. Add resistance training. A 2025 review notes that resistance training may be particularly advantageous in lean people, especially those with low muscle mass. Aerobic activity helps too, and the guidelines aim for about 150 minutes a week.
5. Check and treat the metabolic risk factors. Blood sugar, blood pressure, cholesterol and triglycerides all count toward the diagnosis, and treating them protects the heart as well as the liver.
6. Keep alcohol low. With significant scarring or cirrhosis, the advice is none.

For medicines: there are no drugs approved for lean MASLD specifically. The approved MASH treatments are for adults with MASH and moderate to advanced scarring (F2–F3), without cirrhosis, and the 2025 review notes that evidence for GLP-1 drugs in lean patients is limited. Our guides on resmetirom and Wegovy and GLP-1s explain who they’re for.

Who Should Ask About Lean Fatty Liver?

Consider raising it with your doctor if you have a normal weight and any of the following:

• raised ALT or AST on routine tests, or fat in the liver on a scan done for another reason;
• a larger waist than your weight suggests, or you carry weight mainly around the middle;
• prediabetes, type 2 diabetes, high blood pressure, high triglycerides or low HDL cholesterol;
• a family history of fatty liver, diabetes or cirrhosis.

The usual first step is a blood panel and a FIB-4 score, then a FibroScan if the result isn’t clearly low. Our guide to FibroScan results explains the scan.

The Bottom Line

Fatty liver isn’t only a condition of people with obesity. About one in five people with fatty liver is lean, and having a normal BMI doesn’t exclude inflammation or scarring: pooled data suggest around 3 in 10 lean or non-obese people with NAFLD have significant fibrosis, with wide uncertainty. Possible drivers include visceral fat, low muscle mass, insulin resistance, genetics and a sugar-heavy, low-fiber diet. Large weight loss is usually not the goal. Better food, resistance and aerobic exercise, less alcohol and control of blood sugar, pressure and cholesterol are. If you are at a normal weight with any metabolic risk factor or raised liver enzymes, ask for a scarring check rather than being reassured by the scale.

Sources

• Ye et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis (Lancet Gastroenterology & Hepatology 2020)
• AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease (Rinella et al., Hepatology 2023)
• EASL–EASD–EASO Clinical Practice Guidelines on the management of MASLD (Obesity Facts 2024)
• AASLD: New MASLD Nomenclature (diagnostic criteria)
• Dey P. The emerging phenotype of nonalcoholic fatty liver disease in lean individuals: what’s different? (Frontiers in Endocrinology 2025)
• NIDDK: Treatment for MASLD and MASH (gradual weight loss)
• NIDDK: Symptoms & Causes of MASLD and MASH

This article is for informational purposes only and is not medical advice. Talk to your doctor or hepatologist about your specific situation.